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Bucharest and 6) Central Reference Laboratory Synevo, Bucharest, RomaniaAbstractThis is the ﬁrst report of an OXA-72-producing Acinetobacter baumannii strain in Romania, isolated from chronic leg ulcer samples.
Identiﬁcation of the strain was performed using matrix-assisted laser desorption/ionization time-of-ﬂight mass spectrometry. Presence of
carbapenem resistance genes was investigated by PCR and sequencing. Our data support the spread of the blaOXA-72 gene in Eastern Europe.
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contributed equally to this work.Acinetobacter baumannii is a threatening opportunistic pathogen
in hospital settings and is responsible for various infections,
including bacteraemia, and urinary tract, skin and wound in-
fections. Chronic leg ulcers have an increased risk of infection
initiated either by resident microbiota or by exogenous micro-
organisms because of the absence of epidermis. A. baumannii
contamination, particularly with multidrug-resistant strains, may
lead to signiﬁcant delays in wound healing and development of
sepsis [1]. A. baumannii is often isolated from infected leg ulcers,
mainly in diabetic patients [2]. Resistance to carbapenems (last-
resort β-lactam antibiotics) in A. baumannii is mainly mediated by
carbapenem-hydrolyzing Ambler class D-lactamases (CHDL) and
has a major clinical and epidemiologic impact [3]. According to
their amino acid sequence identities, the main acquired CHDLs
are divided into four subgroups: OXA-23-like, OXA-24/40-like,
OXA-58-like and OXA-143-like [4]. Until now the few studies
performed on carbapenemase-producing A. baumannii isolates
from Romania reported only the occurrence of OXA-23 and
OXA-58, previously identiﬁed worldwide in this species [3–6].© 2016 The Authors. Published by El
This is an open access artiIn the present study, one carbapenem-resistant A. baumannii
strain, ICUB30, isolated from chronic leg ulcers swabs in
Bucharest, Romania, was selected after PCR screening for
CHDL genes blaOXA-23-like, blaOXA-24-like and blaOXA-58-like and
further analysed by different approaches. The isolate was
identiﬁed using a matrix-assisted laser desorption/ionization
time-of-ﬂight mass spectrometry (MALDI-TOF) Biotyper
(Bruker Daltonics, Bremen, Germany). Susceptibility testing
was performed according to the recommendations of the Eu-
ropean Committee on Antimicrobial Susceptibility Testing
(http://www.eucast.org). Resistance to imipenem and mer-
openem was conﬁrmed by the Etest method (minimum inhib-
itory concentration = 16 mg/L). The isolate was negative for
metallo-β-lactamase production in the Etest assay. In addition,
the respective isolate proved to be resistant to ticarcillin, cip-
roﬂoxacin and amikacin but was susceptible to ceftazidime,
cefepime, rifampin and colistin. PCR screening of CHDL genes
revealed the presence of blaOXA-24/40-like gene and was negative
for the other carbapenemase genes tested. The PCR reaction
using primers for blaOXA-24/40-like gene allows the ampliﬁcation
of a speciﬁc gene region. The amplicon was further sequenced
and then analysed using the online application BLAST and the
stand-alone software Genome ARTIST [7]. The analysis of the
amplicon sequence (GenBank accession no. KX264327)
revealed a 99% homology with the corresponding sequences
pertaining to A. baumannii strain MAL carbapenemase OXA-72New Microbes and New Infect 2016; 13: 87–88
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sequence, NZ_LKIB01000052.1) isolated from Serbia and
A. baumannii strain K60 plasmid pAB120 carbapenemase OXA-
72 (GenBank accession no. JX069966) isolated from Lithuania.
The OXA-72 enzyme was ﬁrst reported in A. baumannii in
Thailand in 2004 and is restricted to three main regions: South
America (Brazil and Colombia), southern Asia (Japan, Taiwan)
and Eastern Europe (mainly in Croatia, but also in Lithuania and
Serbia) [8].
To our knowledge, this is the ﬁrst report of the occurrence
of OXA-72 in an A. baumannii clinical isolate from Romania.
Our data support the spread of this OXA-24/40 variant in
Eastern Europe, thus highlighting necessity of developing
effective measures to diagnose and control multidrug-resistant
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